PHGE (BiomX Inc) יחס שווי שוק לשווי בספרים

BiomX Inc. (PHGE) relies on the development of bacteriophage-based treatments, protecting its patents to secure future profits. Team stability is maintained through stock options and the targeted hiring of microbiologists, which retains key talent. The current metric is 0.50. The market dynamics reflected in the quotes on GURU.Markets confirm the technological status of the company, which is investing in the fight against bacterial resistance.

This ratio determines the market value of a business relative to its net assets, revealing the degree of stock overvaluation. By analyzing the historical P/BV multiple of BiomX Inc. (PHGE), an investor can track the trend of market capitalization relative to book value. The metric is calculated as the quotient of the market price and the book value per share. For BiomX Inc. (PHGE), this indicator reflects market expectations regarding the capitalization of the BOLT platform, as the value of intellectual property in phage therapy often exceeds formal balance sheet figures.